GlobeNewsWire
22 Jan 2026, 14:52 UTC · 35w ago
Verdict
Headline takes no side. We score VTGN −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit following a failed Phase 3 clinical trial and an 80% drop in share price.
More negative than 75% of ticker scores this week
The company is mentioned as the subject of a class action lawsuit advisory.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 75% of ticker scores this week
The company is mentioned as the subject of a class action lawsuit advisory.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−57.9%
Price agrees with the score
$0.2670 vs $0.6342 close before publication (Jan 21) · not market-adjusted
VTGN chart →
